Alzheimer's drug approvals & possible impact for patients episode artwork

EPISODE · Jul 20, 2024 · 15 MIN

Alzheimer's drug approvals & possible impact for patients

from Newstalk Weekend

The FDA has approved a second Alzheimer’s drug that can slow the onset of the disease and it is expected that the drug will be approved for use in the EU in the coming months. To the possible impact this could have Luke O'Neill is joined by Prof Sean Kennelly, Clinical Director of the Institute of Memory and Cognition in Tallaght University Hospital & Newstalk presenter, Clare McKenna.

NOW PLAYING

Alzheimer's drug approvals & possible impact for patients

0:00 15:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Newstalk Weekend?

This episode is 15 minutes long.

When was this Newstalk Weekend episode published?

This episode was published on July 20, 2024.

What is this episode about?

The FDA has approved a second Alzheimer’s drug that can slow the onset of the disease and it is expected that the drug will be approved for use in the EU in the coming months. To the possible impact this could have Luke O'Neill is joined by Prof...

Can I download this Newstalk Weekend episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!